Nchi: Uingereza
Lugha: Kiingereza
Chanzo: VMD (Veterinary Medicines Directorate)
Mycoplasma synoviae
MSD Animal Health UK Limited
QI01AE03
Mycoplasma synoviae
Lyophilisate for oculonasal suspension
POM-V - Prescription Only Medicine – Veterinarian
Chickens
Live Bacterial Vaccine
Authorized
2014-04-04
Revised: August 2020 AN: 00299/2020 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis MS Live, lyophilisate for oculonasal suspension for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of reconstituted vaccine: ACTIVE SUBSTANCE: Live attenuated _Mycoplasma synoviae_ strain MS1: 10 6.5 and 10 8.0 CFU 1 1 Colony Forming Units For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Lyophilisate for oculonasal suspension. Lyophilisate: Off-white to yellowish-coloured pellet. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens (layers). 4.2 INDICATIONS FOR USE For the active immunisation of chickens (layers) from 6 weeks of age to reduce air sac lesions, ovary lesions, and a drop in egg production due to infection caused by _Mycoplasma synoviae_. Onset of immunity: 4 weeks. Duration of immunity: 44 weeks. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Vaccinate healthy animals only. Do not use antibiotics or other substances with any antimicrobial activity known to inhibit _Mycoplasma synoviae_. 4.5 SPECIAL PRECAUTIONS FOR USE Revised: August 2020 AN: 00299/2020 Page 2 of 5 Special precautions for use in animals It is not recommended to vaccinate in the presence of (sub-) clinical infection with _Mycoplasma synoviae_. The vaccine strain has been detected in the respiratory tract of vaccinated chickens by PCR at 34 weeks after vaccination. Taking into account the potential spread of the vaccine strain by direct or indirect transmission, all chickens in the chicken house should be vaccinated. Adequate biosecurity measures should be in place, such as change of clothing and boots and the use of properly disinfected equipment. After vaccination interference with serological screening methods for _Mycoplasma_ infections may occur, but the vaccine strain can be differentiated from wildtype _Mycoplasma synoviae_ by PCR or by culture in _Mycoplasma_ growth medium containing nicotinamide instead of NAD. Special pre Soma hati kamili